Hemophilic pseudotumor

Hemophilic pseudotumor is a rare, non-neoplastic, progressively expanding encapsulated hematoma that develops in patients with hemophilia as a consequence of repeated, inadequately treated hemorrhage into bone or adjacent soft tissues.[1][2] The lesion arises from subperiosteal or intraosseous bleeding that fails to resorb; subsequent capsule formation, recurrent intracapsular hemorrhage, and osmotic fluid attraction drive progressive enlargement and pressure-mediated bone destruction.[2][3] In the jaws, the mandible is affected more commonly than the maxilla, and the lesion characteristically presents as a well-demarcated, multilocular, expansile osteolytic mass with cortical thinning or perforation.[4][5] Although the imaging appearance can closely mimic aggressive neoplasms, hemophilic pseudotumor is a clinical entity rather than a pathological neoplasm, and management centers on coagulation factor replacement with or without surgical intervention.[3][6]

The accepted term is hemophilic pseudotumor (also written haemophilic pseudotumour). Synonyms include pseudotumor of hemophilia and hemophilic cyst.[7] Gilbert's classification divides lesions into a proximal type (long bones and pelvis, predominantly in adults) and a distal type (small bones of hands and feet, predominantly in children).[1][2] An alternative classification distinguishes bone (true) pseudotumors, originating within bone, from soft-tissue (false) pseudotumors, originating in muscle or other soft tissues.[3] The term "blood cyst" has been used historically but is now uncommon. The entity was first described by Starker in 1918.[2][4]

• Prevalence: approximately 1%–2% of patients with severe hemophilia; prevalence may reach up to 10% in patients with coagulation factor inhibitors.[1][8]
• Sex: almost exclusively male, reflecting the X-linked inheritance of hemophilia A and B.[2][9]
• Age: wide range; median age at presentation is approximately 29 years for all sites, though jaw pseudotumors show a predilection for children and adolescents.[2][4]
• Hemophilia type: hemophilia A accounts for roughly 82% of reported cases, hemophilia B for approximately 17%. Most patients have severe factor deficiency.[2][10]
• Jaw involvement: rare; a systematic review identified only 40 reported cases in the jaws and paranasal sinuses. The mandible is affected in approximately 75% of jaw cases, with roughly equal right-left distribution; the maxilla accounts for the remainder.[4]
• Trauma history: a preceding traumatic event is documented in 57%–75% of pseudotumors overall; in jaw cases, dental extraction has been identified as a precipitating event in some patients.[2][4]

Presentation

• The hallmark is a painless, slowly enlarging swelling that may grow over months to years. In the jaws, facial asymmetry is the most common presenting complaint.[1][4]
• Intraoral bleeding and masticatory difficulty are frequently reported with jaw lesions.[4]
• Neurological symptoms (paresthesia, dysesthesia) common with long-bone pseudotumors have not been documented in jaw cases.[4]

Examination findings

• A firm, non-tender, bony-hard mass with expansion of the buccal and sometimes lingual cortex.[4]
• Overlying skin and mucosa are typically normal; lymphadenopathy is absent.[4]
• Intraoral examination may reveal vestibular expansion and tilting or displacement of adjacent teeth.[4]

Tempo and complications

• Growth is driven by recurrent intracapsular hemorrhage; lesions that are not treated tend to enlarge progressively.[2][3]
• Potential complications include pathologic fracture, neurovascular compression, uncontrollable hemorrhage, fistula formation through skin or mucosa, and secondary infection.[1][6]
• In the maxillofacial region, aesthetic deformity and functional impairment of mastication are additional concerns.[4]

Red flags

• Rapid enlargement, spontaneous bleeding, or skin breakdown should prompt urgent hematologic consultation.
• Jaw pseudotumors may be the first major manifestation of an undiagnosed bleeding disorder; hemophilia should be considered even without a known history.[4]

Location and distribution

• In the jaws, the mandibular body is the most common site, followed by the angle and ramus; maxillary lesions are less frequent and tend to involve the anterior maxilla or palatal process.[4][11]
• All reported jaw lesions demonstrate intraosseous involvement, in contrast to pseudotumors elsewhere in the body where a substantial proportion are confined to soft tissue.[4]

Periphery and shape

• The lesion characteristically appears as a well-demarcated, multilobulated, expansile radiolucency.[4][5]
• Margins may be corticated with a thin shell of residual bone, or the cortex may be absent where perforation has occurred.[4][5]
• A multilocular (soap-bubble) pattern with internal bony septa or trabeculation is common.[4][12]

Internal architecture

• The internal pattern is predominantly radiolucent with variable internal trabeculation, producing a multilocular appearance.[4][5]
• Occasional radiopaque specks representing dystrophic calcification or ossification within the hematoma wall may be seen.[1][4]
• On cross-sectional imaging, the contents show mixed density corresponding to blood products in various stages of evolution.[5]

Effects on teeth and adjacent structures

• Tooth displacement without root resorption is a characteristic finding that helps distinguish hemophilic pseudotumor from many odontogenic and neoplastic lesions.[4][13]
• Tilting of erupted teeth and displacement of developing tooth buds may be observed.[4]
• The inferior alveolar canal may be displaced inferiorly or obliterated.

Cortical involvement and extent

• Cortical thinning is characteristic; focal cortical perforation, particularly of the buccal plate, is common.[4][5]
• Lingual cortical destruction may also occur but is typically less extensive than buccal involvement.[4][12]
• In the maxilla, lesions may extend into the maxillary sinus with thinning or destruction of sinus walls.[5][11]

Periosteal reaction

• Occasionally, radiated (sunburst) periosteal proliferation is observed, which can closely mimic the appearance of a malignant bone tumor such as osteosarcoma.[5]
• This reactive periosteal new bone formation results from subperiosteal hemorrhage and should not be mistaken for aggressive neoplastic periostitis.[5][7]

Recognized variants

• Maxillary pseudotumors may present as a thinly corticated, fluid-attenuation lesion mimicking an odontogenic cyst, or as diffuse palatal thickening resembling fibrous dysplasia or intraosseous vascular malformation.[11]
• Bilateral jaw involvement has been reported rarely.[4]

CT

• On non-enhanced CT, hemophilic pseudotumor appears as a well-demarcated, expansile mass of mixed density relative to soft tissue, reflecting hemorrhagic contents at different stages.[5]
• Cortical thinning, focal cortical defects, and internal bony septa are well delineated.[4][5]
• Three-dimensional CT reformations are valuable for surgical planning, demonstrating the full extent of buccal and lingual cortical destruction.[4]

MRI

• MRI demonstrates markedly heterogeneous signal intensity on both T1- and T2-weighted sequences, corresponding to blood products in various stages of evolution (acute, subacute, chronic).[5][14]
• A characteristic dark signal rim (hemosiderin ring) on T2-weighted and gradient-echo sequences lines the inner pseudocapsule.[3]
• Septa-like enhancement is seen after gadolinium administration; the solid hematoma contents do not enhance.[5]
• MRI is the preferred modality for monitoring treatment response, as recommended by the World Federation of Hemophilia guidelines.[6]

Angiography

• Catheter angiography or CT angiography may be performed to exclude active arterial feeders and to differentiate pseudotumor from vascular malformations; absence of active vessels within the lesion supports the diagnosis.[4]
• Preoperative embolization can reduce intraoperative blood loss for large, vascularized lesions.[8]

Hemophilic pseudotumor of the jaws lacks pathognomonic radiographic features and can closely mimic both benign and malignant osteolytic lesions.[4][11] The clinical history of hemophilia—or an undiagnosed bleeding diathesis—is the single most important discriminator; however, jaw pseudotumor may be the presenting manifestation of previously unrecognized hemophilia.[4]

The highest-risk diagnostic pitfall is performing an unprotected biopsy or aspiration in a patient with unrecognized hemophilia, which can precipitate life-threatening hemorrhage. When an expansile osteolytic jaw lesion occurs in a male child or young adult, coagulation studies (aPTT, factor VIII/IX levels) should be obtained before any invasive procedure.[1][4]

• The lesion is an encapsulated hematoma rather than a true neoplasm.[3][7]
• The fibrous pseudocapsule consists of three zones: an inner thin layer rich in hemosiderin deposits, a middle zone of dense fibrous tissue, and an outer reticular zone containing elastin fibers and large vessels.[16]
• The cavity contains blood products at various stages of degeneration and lysis—solid clumps of degenerate red blood cells embedded in gelatinous clot.[14][16]
• Hemosiderin-laden macrophages (siderophages) are abundant, particularly in the inner capsular layer and peripheral clot.[14][16]
• Calcification and ossification may develop within the capsule wall, corresponding to the radiopaque foci seen on imaging.[1][7]
• Reactive subperiosteal woven bone formation may be present, correlating with the periosteal reaction observed radiographically.[7]
• No neoplastic cells, atypical mitoses, or tumor osteoid are identified, which distinguishes the lesion from osteosarcoma and other malignancies.[14][17]

Radiologic-pathologic correlation: the multilocular radiolucent pattern corresponds to compartmentalized hemorrhagic cavities separated by fibrous septa; mixed-density or mixed-signal contents reflect blood products at different stages of evolution; and peripheral calcification or ossification accounts for occasional radiopaque foci within the lesion.[5][7][16]

Initial workup and referral

• Diagnosis is primarily clinical and radiographic in a patient with known hemophilia.[1][6]
• Coagulation studies (aPTT, factor VIII or IX activity, inhibitor screen) are essential before any intervention.[4][6]
• Preoperative biopsy is generally contraindicated because of the risk of hemorrhage, infection, and fistula formation; when biopsy is necessary to exclude malignancy, it must be performed under adequate factor replacement.[1][6]
• Multidisciplinary coordination among hematology, oral and maxillofacial surgery, and radiology is recommended.[2]

Conservative management

• The World Federation of Hemophilia guidelines recommend an initial 6-week course of coagulation factor replacement followed by repeat imaging; if the lesion is decreasing, factor replacement is continued with serial imaging for up to three cycles.[6]
• In jaw pseudotumors, conservative factor replacement therapy alone has achieved complete radiographic resolution in reported cases,